309 related articles for article (PubMed ID: 12941902)
1. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
Jones KS; Petrow-Sadowski C; Bertolette DC; Huang Y; Ruscetti FW
J Virol; 2005 Oct; 79(20):12692-702. PubMed ID: 16188972
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
Jassal SR; Pöhler RG; Brighty DW
J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
[TBL] [Abstract][Full Text] [Related]
6. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
7. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
Jassal SR; Lairmore MD; Leigh-Brown AJ; Brighty DW
Virus Res; 2001 Oct; 78(1-2):17-34. PubMed ID: 11520577
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y
AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392
[TBL] [Abstract][Full Text] [Related]
9. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex.
Sagara Y; Inoue Y; Kojima E; Shiraki H; Maeda Y
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1701-4. PubMed ID: 11080813
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
11. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans.
Secchiero P; Sun D; De Vico AL; Crowley RW; Reitz MS; Zauli G; Lusso P; Gallo RC
J Virol; 1997 Jun; 71(6):4571-80. PubMed ID: 9151851
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact.
Ida H; Kurata A; Eguchi K; Yamashita I; Nakashima M; Sakai M; Kawabe Y; Nakamura T; Nagataki S
Antiviral Res; 1994 Feb; 23(2):143-59. PubMed ID: 7908510
[TBL] [Abstract][Full Text] [Related]
13. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389
[TBL] [Abstract][Full Text] [Related]
14. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
[TBL] [Abstract][Full Text] [Related]
15. A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Arp J; LeVatte M; Rowe J; Perkins S; King E; Leystra-Lantz C; Foung SK; Dekaban GA
J Virol; 1996 Nov; 70(11):7349-59. PubMed ID: 8892853
[TBL] [Abstract][Full Text] [Related]
16. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
18. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of chondroitin sulfate type E on the binding step of human T-cell leukemia virus type 1.
Jinno-Oue A; Tanaka A; Shimizu N; Mori T; Sugiura N; Kimata K; Isomura H; Hoshino H
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):621-9. PubMed ID: 23033806
[TBL] [Abstract][Full Text] [Related]
20. The synthetic peptide P-197 inhibits human T-cell leukemia virus type 1 envelope-mediated syncytium formation by a mechanism that is independent of Hsc70.
Brighty DW; Jassal SR
J Virol; 2001 Nov; 75(21):10472-8. PubMed ID: 11581416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]